Publications & Media
Browse scientific publications and company updates in one place.
TargetX Receives Official Certification for Corporate R&D Center
TargetX officially received certification for its Corporate R&D Center on September 15, validating its structured research infrastructure and technological innovation capabilities.
Pancreatic ductal adenocarcinoma: The Vision of Heracles
Co-authored by TargetX Co-CEO Prof. Sang-Won Lee, this Cancer Cell commentary proposes an ecosystem-guided research roadmap for pancreatic cancer: measure, prime, strike and adapt.
TargetX Certified as ‘Innovative Growth Type’ Venture Business
TargetX officially achieved certification as an "Innovative Growth Type" Venture Business on August 19, 2026, validating its technological innovation capabilities and business scalability.
TargetX Selected for 2026 Early-stage Startup Package (Deep-tech Track)
TargetX has been selected for the "2026 Early-stage Startup Package (Deep-tech Track)" by the Ministry of SMEs and Startups (MSS).
A Robust Strategy for High-Throughput and Deep Proteomics by Combining Narrow-Window Data-Independent Acquisition and Isobaric Mass Tagging
A Journal of Proteome Research paper describing a high-throughput deep-proteomics workflow that combines narrow-window DIA with isobaric mass tagging to improve quantitative accuracy and proteome coverage.
TargetX Selected for the 'Pre-Startup Package' by MSS
TargetX was selected for the Ministry of SMEs and Startups' Pre-Startup Package, securing commercialization funding and tailored mentoring for business model advancement and MVP development.